美罗培南与哌拉西林舒巴坦在治疗慢性阻塞性肺病急性发作中的临床对比分析  

The influence of meropenem and piperacillin/sulbactam in treatment of acute exacerbation of chronic obstructive pulmonary disease

作　　者：霍永生[1] 章辉[1] 王伟华[1] 汪利宗[1] 

机构地区：[1]皖南医学院附属弋矶山医院急诊内科,241000

出　　处：《中国实用医药》2012年第36期6-8,共3页China Practical Medicine

摘　　要：目的观察美罗培南与哌拉西林舒巴坦在治疗慢性阻塞性肺病急性发作时的疗效对比及副反应。方法对168例慢性阻塞性肺病急性发作患者随机分为两组,对其细菌情况及临床情况进行分析,幷对治疗情况进行对比?峁?两组均有较高的有效率,但在治疗时间及副作用上有一定差别。结论对不同的抗生素除应了解其身性能特点外,还应尽可能总结其临床应用特点,而不应该片面追求所谓高档抗生素。Objective To observe the efficacy and side effects of meropenem and piperacillin/sulbactam on patients with acute exacerbation of chronic obstructive pulmonary disease（AECOPD）.Methods 168 patients with AECOPD were divided into two groups randomly,and analysis the clinical features and results of laboratory tests.And to contrast the treatments of both.Results The two groups both had the high efficiency,but there are differences on time of treatment and side effects.Conclusion The clinical characteristics of different types of antibiotic is the foundation to select different application.

关 键 词：美罗培南 哌拉西林舒巴坦 慢性阻塞性肺病急性发作 

分 类 号：R563.9[医药卫生—呼吸系统]